Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 24942493)

1.

Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.

López P, Scheel-Toellner D, Rodríguez-Carrio J, Caminal-Montero L, Gordon C, Suárez A.

Rheumatology (Oxford). 2014 Dec;53(12):2249-58. doi: 10.1093/rheumatology/keu249. Epub 2014 Jun 18.

PMID:
24942493
3.

B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.

Ritterhouse LL, Crowe SR, Niewold TB, Merrill JT, Roberts VC, Dedeke AB, Neas BR, Thompson LF, Guthridge JM, James JA.

Arthritis Rheum. 2011 Dec;63(12):3931-41. doi: 10.1002/art.30598.

4.

Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.

Morel J, Roubille C, Planelles L, Rocha C, Fernandez L, Lukas C, Hahne M, Combe B.

Ann Rheum Dis. 2009 Jun;68(6):997-1002. doi: 10.1136/ard.2008.090928. Epub 2008 Aug 2.

PMID:
18676986
5.

Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.

Carter RH, Zhao H, Liu X, Pelletier M, Chatham W, Kimberly R, Zhou T.

Arthritis Rheum. 2005 Dec;52(12):3943-54.

6.

Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort.

McCarthy EM, Lee RZ, Ní Gabhann J, Smith S, Cunnane G, Doran MF, Howard D, O'Connell P, Kearns G, Jefferies CA.

Rheumatology (Oxford). 2013 Jul;52(7):1279-84. doi: 10.1093/rheumatology/ket120. Epub 2013 Mar 11.

PMID:
23479724
7.

B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.

Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, Roschke V, Wu Y, Baker KP, Hilbert DM.

Arthritis Rheum. 2003 Dec;48(12):3475-86.

8.

Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus.

Ju S, Zhang D, Wang Y, Ni H, Kong X, Zhong R.

Clin Biochem. 2006 Dec;39(12):1131-7. Epub 2006 Oct 5.

PMID:
17069785
9.

Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells.

Eloranta ML, Lövgren T, Finke D, Mathsson L, Rönnelid J, Kastner B, Alm GV, Rönnblom L.

Arthritis Rheum. 2009 Aug;60(8):2418-27. doi: 10.1002/art.24686.

10.

Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function.

Gerl V, Lischka A, Panne D, Grossmann P, Berthold R, Hoyer BF, Biesen R, Bruns A, Alexander T, Jacobi A, Dörner T, Burmester GR, Radbruch A, Hiepe F.

Ann Rheum Dis. 2010 Jul;69(7):1370-7. doi: 10.1136/ard.2009.111021. Epub 2009 Oct 22.

PMID:
19854711
11.

C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes.

Mold C, Clos TW.

Arthritis Rheum. 2013 Jul;65(7):1891-901. doi: 10.1002/art.37968.

12.

B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.

Hong SD, Reiff A, Yang HT, Migone TS, Ward CD, Marzan K, Shaham B, Phei WC, Garza J, Bernstein B, Stohl W.

Arthritis Rheum. 2009 Nov;60(11):3400-9. doi: 10.1002/art.24902.

13.

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.

Petri M, Stohl W, Chatham W, McCune WJ, Chevrier M, Ryel J, Recta V, Zhong J, Freimuth W.

Arthritis Rheum. 2008 Aug;58(8):2453-9. doi: 10.1002/art.23678.

14.

B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.

Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, Stohl W.

Ann Rheum Dis. 2008 Jul;67(7):1011-6. Epub 2007 Oct 25.

PMID:
17962238
15.

Synthesis and release of B-lymphocyte stimulator from myeloid cells.

Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, Sosnovtseva S, Carrell JA, Feng P, Giri JG, Hilbert DM.

Blood. 2001 Jan 1;97(1):198-204.

16.

C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes.

Santer DM, Hall BE, George TC, Tangsombatvisit S, Liu CL, Arkwright PD, Elkon KB.

J Immunol. 2010 Oct 15;185(8):4738-49. doi: 10.4049/jimmunol.1001731. Epub 2010 Sep 15.

17.

Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.

Biesen R, Demir C, Barkhudarova F, Grün JR, Steinbrich-Zöllner M, Backhaus M, Häupl T, Rudwaleit M, Riemekasten G, Radbruch A, Hiepe F, Burmester GR, Grützkau A.

Arthritis Rheum. 2008 Apr;58(4):1136-45. doi: 10.1002/art.23404.

19.

Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.

Robak E, Smolewski P, Wozniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.

Eur Cytokine Netw. 2004 Jul-Sep;15(3):222-30.

PMID:
15542447
20.

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J.

Science. 2001 Nov 16;294(5546):1540-3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk